Biosimilarity the FDA perspective
➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạmNội dung chi tiết: Biosimilarity the FDA perspective
Biosimilarity the FDA perspective
Arg^ỉoeẹtìOHỀ ■ ộ*5! -íA.LeucineBIOSIMILARITYSarfaraz K. NiaziTaytor í. Francis CroupBiosimilarityThe FDA PerspectiveTaylor & FrancisTaylor &. Francis Biosimilarity the FDA perspectives Grouphttp://taylorandfrancis.comBiosimilarityThe FDA PerspectiveSarfaraz K. Niazi, PhD, SI, FRSB, FPAMS, FACB Adjunct Professor, Biopharmaceutical Sciences, University of Illinois (U.S.), University of Houston (U.S.), HEJ ResearchInstitute (PK), and National University of Science andCRC PressTaylo Biosimilarity the FDA perspectiver & Francis Group6000 Broken Sound Parkway NW, Suite 300Boca Raton. FL 33-487-2742c 2019 by Taylor & Francis Group. LLCCRC Press IS an imprint of TaylBiosimilarity the FDA perspective
or & Francis Group, an Informa businessNo claim to original U.S Government worksPrinted on acid-tree paperVersion Date: 20151116International StandardArg^ỉoeẹtìOHỀ ■ ộ*5! -íA.LeucineBIOSIMILARITYSarfaraz K. NiaziTaytor í. Francis CroupBiosimilarityThe FDA PerspectiveTaylor & FrancisTaylor &. Francis Biosimilarity the FDA perspectiveve been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use T e authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication Biosimilarity the FDA perspectiveand apologize to copyright holders if permission to publish in this form has not been obtained It any copyright material has not been acknowledged pleBiosimilarity the FDA perspective
ase write and let US know so we may rectify in any future reprintExcept as permitted under U.S. Copyright Law. no part of this book may be reprinted, Arg^ỉoeẹtìOHỀ ■ ộ*5! -íA.LeucineBIOSIMILARITYSarfaraz K. NiaziTaytor í. Francis CroupBiosimilarityThe FDA PerspectiveTaylor & FrancisTaylor &. Francis Biosimilarity the FDA perspectiveg, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishersFor permission to photocopy or use material electronically from this work, please access wwwcopyright.com (http: WWW copy right com I or contact the Copyright Clearance Ce Biosimilarity the FDA perspectiventer. Inc. (CCC). 222 Rosewood Drive. Danvers. MA 01923. 978-750-8400 ccc is a not-for-profit organization that provides licenses and registration forBiosimilarity the FDA perspective
a variety of users For organizations that have been granted a photocopy license by the ccc. a separate system of payment has been arrangedTrademark NoArg^ỉoeẹtìOHỀ ■ ộ*5! -íA.LeucineBIOSIMILARITYSarfaraz K. NiaziTaytor í. Francis CroupBiosimilarityThe FDA PerspectiveTaylor & FrancisTaylor &. Francis Biosimilarity the FDA perspectivefringeLibrary of Congress Cataloging-in- Publication DataNames: Niazt. Sarfaraz. 1949-. authorTitle- Biosimilanty: the FDA perspective Sarfaraz K. Niazt Biosimilarity the FDA perspectiveArg^ỉoeẹtìOHỀ ■ ộ*5! -íA.LeucineBIOSIMILARITYSarfaraz K. NiaziTaytor í. Francis CroupBiosimilarityThe FDA PerspectiveTaylor & FrancisTaylor &. FrancisGọi ngay
Chat zalo
Facebook